Latest Competition News

Microequities Asset Management Group Limited has reported a robust 46.4% increase in profit after tax for the half-year ended December 2024, alongside a record $650 million in Funds Under Management and a raised interim dividend.

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

Pengana Capital Group reports a rise in Funds Under Management to $3.64 billion as of January 31, 2025, following significant distributions to investors. The firm’s half-year audited results are due next month, setting the stage for further insights.

BMG Resources is ramping up its drilling efforts at the Abercromby Gold Project with assays from Phase 1 drilling imminent, aiming to expand its existing 518,000oz gold resource. Concurrently, a new drilling program is planned for the nearby Bullabulling Project following a major regional acquisition.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Abacus Storage King reported a modest 1.1% increase in statutory profit for HY25, underpinned by resilient operating metrics and a robust balance sheet. The company’s multi-pronged growth strategy, including acquisitions and a substantial development pipeline, supports a confident outlook with reaffirmed distribution guidance.

Abacus Storage King (ASK) reported a robust half-year performance for HY25, with net profit soaring to $67.8 million and key operating metrics showing solid growth. The company’s strategic acquisitions, development pipeline, and platform initiatives underpin its confident outlook.

EQ Resources Ltd updates investors on its proposed acquisition of Tungsten Metals Group, highlighting completed due diligence but pending definitive agreements as discussions continue beyond the exclusivity period.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.

Charter Hall Retail REIT reported a 3.0% same property net property income growth and a stable 98.7% occupancy rate in its 2025 half-year results, while integrating the Hotel Property Investments acquisition to enhance future income growth.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.